Here, we have extended these findings by showing that increasing serum PRL to levels similar to those (40 ng/ml) found in the circulation of some patients with RA [35] reduced systemic levels of CRP and TNFα, two osteoclastogenic cytokines [2, 3, 31]. This evidence concerns the gene PRL and rheumatoid arthritis.